Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | Diabetic Medicine |
| Volume | 19 |
| Issue number | 9 |
| Pages (from-to) | 790-2 |
| Number of pages | 3 |
| ISSN | 0742-3071 |
| Publication status | Published - Sep 2002 |
- Adult, Amyloid, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glucagon, Glucagon-Like Peptide 1, Humans, Hyperglycemia, Hypoglycemic Agents, Islet Amyloid Polypeptide, Male, Peptide Fragments, Protein Precursors
Research areas
ID: 132056414